{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T08:57:58Z","timestamp":1698915478181},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1614,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1365-2133.2010.10155.x","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T09:57:20Z","timestamp":1291024640000},"page":"884-886","source":"Crossref","is-referenced-by-count":2,"title":["Recurrent bullous erythema multiforme treated with topical tacrolimus 0\u00b71% ointment"],"prefix":"10.1093","volume":"164","author":[{"given":"E.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,4,4]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.1993.tb00232.x","article-title":"Recurrent erythema multiform: clinical features and treatment in a large series of patients","volume":"128","author":"Schofield","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0190-9622(84)80090-0","article-title":"Erythema multiforme: clinical, histopathologic, and immunologic study","volume":"10","author":"Howland","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1995.tb05024.x","article-title":"A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme","volume":"132","author":"Tatnall","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaad.2009.06.046","article-title":"Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007","volume":"62","author":"Wetter","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1542\/peds.89.1.32","article-title":"Herpes simplex virus in childhood erythema multiforme","volume":"89","author":"Weston","year":"1992","journal-title":"Pediatrics"},{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archpedi.1997.02170470048009","article-title":"Herpes simplex virus-associated erythema multiforme in prepubertal children","volume":"151","author":"Weston","year":"1997","journal-title":"Arch Paediatr Adolesc Med"},{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB7|cit7","first-page":"1215","article-title":"Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme; interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions","volume":"124","author":"Kokuba","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB8|cit8","first-page":"287","volume-title":"Dermatology","author":"French","year":"2008"},{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/bmj.38376.439653.D3","article-title":"Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials","volume":"330","author":"Ashcroft","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2010.10155.x-BIB10|cit10","first-page":"331","article-title":"Potential future dermatological indications for tacrolimus ointment","volume":"13","author":"Ruzicka","year":"2003","journal-title":"Eur J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.10155.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.10155.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T09:24:01Z","timestamp":1685870641000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/164\/4\/884\/6642969"}},"subtitle":["Correspondence"],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10155.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}